Skip to main content

Coagulo Medical Technologies

Coagulo Medical Technologies

Coagulo Medical Technologies, Inc

Coagulo is transforming medicine through the introduction of the world’s first point-of-care (PoC) precision-medicine platform for coagulation. Current coagulation testing is based on assays that were developed over a half-century ago, which are capable of providing only general information on the coagulation pathway and cannot offer much-needed insight into the specific cause of abnormal coagulation function. These outdated tests, which predate modern drugs, do not provide physicians with the information they need for fast and accurate diagnoses, forcing them to make critical treatment decisions based on little more than clinical intuition. In fact, because testing technology has not kept up with drug development, anticoagulants are now the #1 cause of drug-related adverse events and hospitalizations in the U.S.